United Kingdom Kidney Stone Market

Kidney Stone Comprehensive Study by Stone Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Offering (Drugs, Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others)), Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), End User (Hospital & Clinic, Diagnostic Centers, Ambulatory Surgical Centers, Others) Players and Region - United Kingdom Market Outlook to 2028

Kidney Stone Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 5.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Kidney Stone
A kidney stone (also called a renal calculus) is a hard, pebble-like mass that forms in the kidneys. They are usually made of minerals like calcium oxalate, calcium phosphate, or uric acid, which crystallize in the concentrated urine inside your kidneys. These stones can cause severe pain, especially when they move around inside your urinary tract. Certain medical conditions like gout, polycystic kidney disease, and recurrent urinary tract infections increase the risk of kidney stone. Although, mostly used treatments for kidney stone are Laser Lithotripsy and Micro-surgery.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
CAGR5.6%


Competition among existing players is due to the stiff market share occupied by leading players. The companies are implementing strategic activities such as acquisition and mergers along with collaboration with companies in other industries to help them in improving sustenance and maintaining their competitive advantages. Analyst at AMA Research estimates that United States & German Players will contribute the maximum growth to United Kingdom Kidney Stone market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Stryker Corporation (United States), Olympus Corporation (Japan), BD (United States), Boston Scientific (United States), Johnson & Johnson (United States), Steris plc (Ireland), Coloplast A/S (Denmark), Dornier MedTech (Germany), Richard Wolf GmbH (Germany), Siemens Healthineers (Germany) and Karl Storz (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of United Kingdom Kidney Stone market by and Region.



On the basis of geography, the market of Kidney Stone has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Stone Type, the sub-segment i.e. Calcium Oxalate Stones will boost the Kidney Stone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment Type, the sub-segment i.e. Medications will boost the Kidney Stone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Offering, the sub-segment i.e. Drugs will boost the Kidney Stone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Application, the sub-segment i.e. Kidney Stones will boost the Kidney Stone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital & Clinic will boost the Kidney Stone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Adoption of Minimally Invasive Stone Removal Procedure and The Growing Awareness of the Importance of Early Diagnosis and Treatment

Market Growth Drivers:
Insufficient Fluid Intake Drive the Market Growth and Growing Geriatric Population is Significant Driver of the Kidney Stone Market

Challenges:
Recurrence and Chronicity of Kidney Stones and Shortage of Skilled Healthcare Professional

Restraints:
High Cost of Automated Diagnostic Devices

Opportunities:
Increasing Demand of Treatment option for Kidney Stone Like Laser Lithotripsy and Micro-Surgery Offer Less Pain and The Increasing Focused on Development of New Techniques

Market Leaders and their expansionary development strategies
In July 2023, Boston Scientific, a leading medical device company, acquired Urotronic Inc., a developer of innovative ureteral access systems used in minimally invasive stone removal procedures. This acquisition strengthens Boston Scientific's position in the urology market and provides them with access to Urotronic's advanced technology.
In October 2023, Olympus, a renowned manufacturer of medical imaging equipment, launched the LithoVue System. This advanced imaging system combines X-ray and ultrasound technology to provide a more detailed and accurate picture of kidney stones, aiding in diagnosis and treatment planning.


Key Target Audience
Research Organization, Government Bodies, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Stone Type
  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

By Treatment Type
  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

By Offering
  • Drugs
  • Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others)

By Application
  • Kidney Stones
  • Ureteral Stones
  • Pancreatic Stones
  • Bile Duct Stones

By End User
  • Hospital & Clinic
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Insufficient Fluid Intake Drive the Market Growth
      • 3.2.2. Growing Geriatric Population is Significant Driver of the Kidney Stone Market
    • 3.3. Market Challenges
      • 3.3.1. Recurrence and Chronicity of Kidney Stones
      • 3.3.2. Shortage of Skilled Healthcare Professional
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Minimally Invasive Stone Removal Procedure
      • 3.4.2. The Growing Awareness of the Importance of Early Diagnosis and Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. United Kingdom Kidney Stone, by Stone Type, Treatment Type, Offering, Application, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. United Kingdom Kidney Stone (Value)
      • 5.2.1. United Kingdom Kidney Stone by: Application (Value)
        • 5.2.1.1. Kidney Stones
        • 5.2.1.2. Ureteral Stones
        • 5.2.1.3. Pancreatic Stones
        • 5.2.1.4. Bile Duct Stones
      • 5.2.2. United Kingdom Kidney Stone by: Stone Type (Value)
        • 5.2.2.1. Calcium Oxalate Stones
        • 5.2.2.2. Uric Acid
        • 5.2.2.3. Struvite Kidney Stones
        • 5.2.2.4. Cystine Stones
        • 5.2.2.5. Calcium Phosphate Stones
      • 5.2.3. United Kingdom Kidney Stone by: Treatment Type (Value)
        • 5.2.3.1. Medications
        • 5.2.3.2. Extracorporeal Shock Wave Lithotripsy
        • 5.2.3.3. Ureteroscopy
        • 5.2.3.4. Percutaneous Nephrolithotomy
      • 5.2.4. United Kingdom Kidney Stone by: Offering (Value)
        • 5.2.4.1. Drugs
        • 5.2.4.2. Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others)
      • 5.2.5. United Kingdom Kidney Stone by: Application (Value)
        • 5.2.5.1. Kidney Stones
        • 5.2.5.2. Ureteral Stones
        • 5.2.5.3. Pancreatic Stones
        • 5.2.5.4. Bile Duct Stones
      • 5.2.6. United Kingdom Kidney Stone by: End User (Value)
        • 5.2.6.1. Hospital & Clinic
        • 5.2.6.2. Diagnostic Centers
        • 5.2.6.3. Ambulatory Surgical Centers
        • 5.2.6.4. Others
      • 5.2.7. United Kingdom Kidney Stone Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Kidney Stone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Olympus Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BD (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Steris plc (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Coloplast A/S (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Dornier MedTech (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Richard Wolf GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Siemens Healthineers (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Karl Storz (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. United Kingdom Kidney Stone Sale, by Stone Type, Treatment Type, Offering, Application, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. United Kingdom Kidney Stone (Value)
      • 7.2.1. United Kingdom Kidney Stone by: Application (Value)
        • 7.2.1.1. Kidney Stones
        • 7.2.1.2. Ureteral Stones
        • 7.2.1.3. Pancreatic Stones
        • 7.2.1.4. Bile Duct Stones
      • 7.2.2. United Kingdom Kidney Stone by: Stone Type (Value)
        • 7.2.2.1. Calcium Oxalate Stones
        • 7.2.2.2. Uric Acid
        • 7.2.2.3. Struvite Kidney Stones
        • 7.2.2.4. Cystine Stones
        • 7.2.2.5. Calcium Phosphate Stones
      • 7.2.3. United Kingdom Kidney Stone by: Treatment Type (Value)
        • 7.2.3.1. Medications
        • 7.2.3.2. Extracorporeal Shock Wave Lithotripsy
        • 7.2.3.3. Ureteroscopy
        • 7.2.3.4. Percutaneous Nephrolithotomy
      • 7.2.4. United Kingdom Kidney Stone by: Offering (Value)
        • 7.2.4.1. Drugs
        • 7.2.4.2. Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others)
      • 7.2.5. United Kingdom Kidney Stone by: Application (Value)
        • 7.2.5.1. Kidney Stones
        • 7.2.5.2. Ureteral Stones
        • 7.2.5.3. Pancreatic Stones
        • 7.2.5.4. Bile Duct Stones
      • 7.2.6. United Kingdom Kidney Stone by: End User (Value)
        • 7.2.6.1. Hospital & Clinic
        • 7.2.6.2. Diagnostic Centers
        • 7.2.6.3. Ambulatory Surgical Centers
        • 7.2.6.4. Others
      • 7.2.7. United Kingdom Kidney Stone Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Kidney Stone: by Application(USD Million)
  • Table 2. Kidney Stone Kidney Stones , by Region USD Million (2017-2022)
  • Table 3. Kidney Stone Ureteral Stones , by Region USD Million (2017-2022)
  • Table 4. Kidney Stone Pancreatic Stones , by Region USD Million (2017-2022)
  • Table 5. Kidney Stone Bile Duct Stones , by Region USD Million (2017-2022)
  • Table 6. Kidney Stone: by Stone Type(USD Million)
  • Table 7. Kidney Stone Calcium Oxalate Stones , by Region USD Million (2017-2022)
  • Table 8. Kidney Stone Uric Acid , by Region USD Million (2017-2022)
  • Table 9. Kidney Stone Struvite Kidney Stones , by Region USD Million (2017-2022)
  • Table 10. Kidney Stone Cystine Stones , by Region USD Million (2017-2022)
  • Table 11. Kidney Stone Calcium Phosphate Stones , by Region USD Million (2017-2022)
  • Table 12. Kidney Stone: by Treatment Type(USD Million)
  • Table 13. Kidney Stone Medications , by Region USD Million (2017-2022)
  • Table 14. Kidney Stone Extracorporeal Shock Wave Lithotripsy , by Region USD Million (2017-2022)
  • Table 15. Kidney Stone Ureteroscopy , by Region USD Million (2017-2022)
  • Table 16. Kidney Stone Percutaneous Nephrolithotomy , by Region USD Million (2017-2022)
  • Table 17. Kidney Stone: by Offering(USD Million)
  • Table 18. Kidney Stone Drugs , by Region USD Million (2017-2022)
  • Table 19. Kidney Stone Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others) , by Region USD Million (2017-2022)
  • Table 20. Kidney Stone: by Application(USD Million)
  • Table 21. Kidney Stone Kidney Stones , by Region USD Million (2017-2022)
  • Table 22. Kidney Stone Ureteral Stones , by Region USD Million (2017-2022)
  • Table 23. Kidney Stone Pancreatic Stones , by Region USD Million (2017-2022)
  • Table 24. Kidney Stone Bile Duct Stones , by Region USD Million (2017-2022)
  • Table 25. Kidney Stone: by End User(USD Million)
  • Table 26. Kidney Stone Hospital & Clinic , by Region USD Million (2017-2022)
  • Table 27. Kidney Stone Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 28. Kidney Stone Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 29. Kidney Stone Others , by Region USD Million (2017-2022)
  • Table 30. South America Kidney Stone, by Country USD Million (2017-2022)
  • Table 31. South America Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 32. South America Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 33. South America Kidney Stone, by Offering USD Million (2017-2022)
  • Table 34. South America Kidney Stone, by Application USD Million (2017-2022)
  • Table 35. South America Kidney Stone, by End User USD Million (2017-2022)
  • Table 36. Brazil Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 37. Brazil Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 38. Brazil Kidney Stone, by Offering USD Million (2017-2022)
  • Table 39. Brazil Kidney Stone, by Application USD Million (2017-2022)
  • Table 40. Brazil Kidney Stone, by End User USD Million (2017-2022)
  • Table 41. Argentina Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 42. Argentina Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 43. Argentina Kidney Stone, by Offering USD Million (2017-2022)
  • Table 44. Argentina Kidney Stone, by Application USD Million (2017-2022)
  • Table 45. Argentina Kidney Stone, by End User USD Million (2017-2022)
  • Table 46. Rest of South America Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 47. Rest of South America Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 48. Rest of South America Kidney Stone, by Offering USD Million (2017-2022)
  • Table 49. Rest of South America Kidney Stone, by Application USD Million (2017-2022)
  • Table 50. Rest of South America Kidney Stone, by End User USD Million (2017-2022)
  • Table 51. Asia Pacific Kidney Stone, by Country USD Million (2017-2022)
  • Table 52. Asia Pacific Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 53. Asia Pacific Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 54. Asia Pacific Kidney Stone, by Offering USD Million (2017-2022)
  • Table 55. Asia Pacific Kidney Stone, by Application USD Million (2017-2022)
  • Table 56. Asia Pacific Kidney Stone, by End User USD Million (2017-2022)
  • Table 57. China Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 58. China Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 59. China Kidney Stone, by Offering USD Million (2017-2022)
  • Table 60. China Kidney Stone, by Application USD Million (2017-2022)
  • Table 61. China Kidney Stone, by End User USD Million (2017-2022)
  • Table 62. Japan Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 63. Japan Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 64. Japan Kidney Stone, by Offering USD Million (2017-2022)
  • Table 65. Japan Kidney Stone, by Application USD Million (2017-2022)
  • Table 66. Japan Kidney Stone, by End User USD Million (2017-2022)
  • Table 67. India Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 68. India Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 69. India Kidney Stone, by Offering USD Million (2017-2022)
  • Table 70. India Kidney Stone, by Application USD Million (2017-2022)
  • Table 71. India Kidney Stone, by End User USD Million (2017-2022)
  • Table 72. South Korea Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 73. South Korea Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 74. South Korea Kidney Stone, by Offering USD Million (2017-2022)
  • Table 75. South Korea Kidney Stone, by Application USD Million (2017-2022)
  • Table 76. South Korea Kidney Stone, by End User USD Million (2017-2022)
  • Table 77. Taiwan Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 78. Taiwan Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 79. Taiwan Kidney Stone, by Offering USD Million (2017-2022)
  • Table 80. Taiwan Kidney Stone, by Application USD Million (2017-2022)
  • Table 81. Taiwan Kidney Stone, by End User USD Million (2017-2022)
  • Table 82. Australia Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 83. Australia Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 84. Australia Kidney Stone, by Offering USD Million (2017-2022)
  • Table 85. Australia Kidney Stone, by Application USD Million (2017-2022)
  • Table 86. Australia Kidney Stone, by End User USD Million (2017-2022)
  • Table 87. Rest of Asia-Pacific Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 88. Rest of Asia-Pacific Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 89. Rest of Asia-Pacific Kidney Stone, by Offering USD Million (2017-2022)
  • Table 90. Rest of Asia-Pacific Kidney Stone, by Application USD Million (2017-2022)
  • Table 91. Rest of Asia-Pacific Kidney Stone, by End User USD Million (2017-2022)
  • Table 92. Europe Kidney Stone, by Country USD Million (2017-2022)
  • Table 93. Europe Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 94. Europe Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 95. Europe Kidney Stone, by Offering USD Million (2017-2022)
  • Table 96. Europe Kidney Stone, by Application USD Million (2017-2022)
  • Table 97. Europe Kidney Stone, by End User USD Million (2017-2022)
  • Table 98. Germany Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 99. Germany Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 100. Germany Kidney Stone, by Offering USD Million (2017-2022)
  • Table 101. Germany Kidney Stone, by Application USD Million (2017-2022)
  • Table 102. Germany Kidney Stone, by End User USD Million (2017-2022)
  • Table 103. France Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 104. France Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 105. France Kidney Stone, by Offering USD Million (2017-2022)
  • Table 106. France Kidney Stone, by Application USD Million (2017-2022)
  • Table 107. France Kidney Stone, by End User USD Million (2017-2022)
  • Table 108. Italy Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 109. Italy Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 110. Italy Kidney Stone, by Offering USD Million (2017-2022)
  • Table 111. Italy Kidney Stone, by Application USD Million (2017-2022)
  • Table 112. Italy Kidney Stone, by End User USD Million (2017-2022)
  • Table 113. United Kingdom Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 114. United Kingdom Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 115. United Kingdom Kidney Stone, by Offering USD Million (2017-2022)
  • Table 116. United Kingdom Kidney Stone, by Application USD Million (2017-2022)
  • Table 117. United Kingdom Kidney Stone, by End User USD Million (2017-2022)
  • Table 118. Netherlands Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 119. Netherlands Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 120. Netherlands Kidney Stone, by Offering USD Million (2017-2022)
  • Table 121. Netherlands Kidney Stone, by Application USD Million (2017-2022)
  • Table 122. Netherlands Kidney Stone, by End User USD Million (2017-2022)
  • Table 123. Rest of Europe Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 124. Rest of Europe Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 125. Rest of Europe Kidney Stone, by Offering USD Million (2017-2022)
  • Table 126. Rest of Europe Kidney Stone, by Application USD Million (2017-2022)
  • Table 127. Rest of Europe Kidney Stone, by End User USD Million (2017-2022)
  • Table 128. MEA Kidney Stone, by Country USD Million (2017-2022)
  • Table 129. MEA Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 130. MEA Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 131. MEA Kidney Stone, by Offering USD Million (2017-2022)
  • Table 132. MEA Kidney Stone, by Application USD Million (2017-2022)
  • Table 133. MEA Kidney Stone, by End User USD Million (2017-2022)
  • Table 134. Middle East Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 135. Middle East Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 136. Middle East Kidney Stone, by Offering USD Million (2017-2022)
  • Table 137. Middle East Kidney Stone, by Application USD Million (2017-2022)
  • Table 138. Middle East Kidney Stone, by End User USD Million (2017-2022)
  • Table 139. Africa Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 140. Africa Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 141. Africa Kidney Stone, by Offering USD Million (2017-2022)
  • Table 142. Africa Kidney Stone, by Application USD Million (2017-2022)
  • Table 143. Africa Kidney Stone, by End User USD Million (2017-2022)
  • Table 144. North America Kidney Stone, by Country USD Million (2017-2022)
  • Table 145. North America Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 146. North America Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 147. North America Kidney Stone, by Offering USD Million (2017-2022)
  • Table 148. North America Kidney Stone, by Application USD Million (2017-2022)
  • Table 149. North America Kidney Stone, by End User USD Million (2017-2022)
  • Table 150. United States Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 151. United States Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 152. United States Kidney Stone, by Offering USD Million (2017-2022)
  • Table 153. United States Kidney Stone, by Application USD Million (2017-2022)
  • Table 154. United States Kidney Stone, by End User USD Million (2017-2022)
  • Table 155. Canada Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 156. Canada Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 157. Canada Kidney Stone, by Offering USD Million (2017-2022)
  • Table 158. Canada Kidney Stone, by Application USD Million (2017-2022)
  • Table 159. Canada Kidney Stone, by End User USD Million (2017-2022)
  • Table 160. Mexico Kidney Stone, by Stone Type USD Million (2017-2022)
  • Table 161. Mexico Kidney Stone, by Treatment Type USD Million (2017-2022)
  • Table 162. Mexico Kidney Stone, by Offering USD Million (2017-2022)
  • Table 163. Mexico Kidney Stone, by Application USD Million (2017-2022)
  • Table 164. Mexico Kidney Stone, by End User USD Million (2017-2022)
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Kidney Stone: by Application(USD Million)
  • Table 177. Kidney Stone Kidney Stones , by Region USD Million (2023-2028)
  • Table 178. Kidney Stone Ureteral Stones , by Region USD Million (2023-2028)
  • Table 179. Kidney Stone Pancreatic Stones , by Region USD Million (2023-2028)
  • Table 180. Kidney Stone Bile Duct Stones , by Region USD Million (2023-2028)
  • Table 181. Kidney Stone: by Stone Type(USD Million)
  • Table 182. Kidney Stone Calcium Oxalate Stones , by Region USD Million (2023-2028)
  • Table 183. Kidney Stone Uric Acid , by Region USD Million (2023-2028)
  • Table 184. Kidney Stone Struvite Kidney Stones , by Region USD Million (2023-2028)
  • Table 185. Kidney Stone Cystine Stones , by Region USD Million (2023-2028)
  • Table 186. Kidney Stone Calcium Phosphate Stones , by Region USD Million (2023-2028)
  • Table 187. Kidney Stone: by Treatment Type(USD Million)
  • Table 188. Kidney Stone Medications , by Region USD Million (2023-2028)
  • Table 189. Kidney Stone Extracorporeal Shock Wave Lithotripsy , by Region USD Million (2023-2028)
  • Table 190. Kidney Stone Ureteroscopy , by Region USD Million (2023-2028)
  • Table 191. Kidney Stone Percutaneous Nephrolithotomy , by Region USD Million (2023-2028)
  • Table 192. Kidney Stone: by Offering(USD Million)
  • Table 193. Kidney Stone Drugs , by Region USD Million (2023-2028)
  • Table 194. Kidney Stone Devices (Lithotripters, Stone Removal Devices, Ureteral stents, Others) , by Region USD Million (2023-2028)
  • Table 195. Kidney Stone: by Application(USD Million)
  • Table 196. Kidney Stone Kidney Stones , by Region USD Million (2023-2028)
  • Table 197. Kidney Stone Ureteral Stones , by Region USD Million (2023-2028)
  • Table 198. Kidney Stone Pancreatic Stones , by Region USD Million (2023-2028)
  • Table 199. Kidney Stone Bile Duct Stones , by Region USD Million (2023-2028)
  • Table 200. Kidney Stone: by End User(USD Million)
  • Table 201. Kidney Stone Hospital & Clinic , by Region USD Million (2023-2028)
  • Table 202. Kidney Stone Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 203. Kidney Stone Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 204. Kidney Stone Others , by Region USD Million (2023-2028)
  • Table 205. South America Kidney Stone, by Country USD Million (2023-2028)
  • Table 206. South America Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 207. South America Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 208. South America Kidney Stone, by Offering USD Million (2023-2028)
  • Table 209. South America Kidney Stone, by Application USD Million (2023-2028)
  • Table 210. South America Kidney Stone, by End User USD Million (2023-2028)
  • Table 211. Brazil Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 212. Brazil Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 213. Brazil Kidney Stone, by Offering USD Million (2023-2028)
  • Table 214. Brazil Kidney Stone, by Application USD Million (2023-2028)
  • Table 215. Brazil Kidney Stone, by End User USD Million (2023-2028)
  • Table 216. Argentina Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 217. Argentina Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 218. Argentina Kidney Stone, by Offering USD Million (2023-2028)
  • Table 219. Argentina Kidney Stone, by Application USD Million (2023-2028)
  • Table 220. Argentina Kidney Stone, by End User USD Million (2023-2028)
  • Table 221. Rest of South America Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 222. Rest of South America Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 223. Rest of South America Kidney Stone, by Offering USD Million (2023-2028)
  • Table 224. Rest of South America Kidney Stone, by Application USD Million (2023-2028)
  • Table 225. Rest of South America Kidney Stone, by End User USD Million (2023-2028)
  • Table 226. Asia Pacific Kidney Stone, by Country USD Million (2023-2028)
  • Table 227. Asia Pacific Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 228. Asia Pacific Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 229. Asia Pacific Kidney Stone, by Offering USD Million (2023-2028)
  • Table 230. Asia Pacific Kidney Stone, by Application USD Million (2023-2028)
  • Table 231. Asia Pacific Kidney Stone, by End User USD Million (2023-2028)
  • Table 232. China Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 233. China Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 234. China Kidney Stone, by Offering USD Million (2023-2028)
  • Table 235. China Kidney Stone, by Application USD Million (2023-2028)
  • Table 236. China Kidney Stone, by End User USD Million (2023-2028)
  • Table 237. Japan Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 238. Japan Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 239. Japan Kidney Stone, by Offering USD Million (2023-2028)
  • Table 240. Japan Kidney Stone, by Application USD Million (2023-2028)
  • Table 241. Japan Kidney Stone, by End User USD Million (2023-2028)
  • Table 242. India Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 243. India Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 244. India Kidney Stone, by Offering USD Million (2023-2028)
  • Table 245. India Kidney Stone, by Application USD Million (2023-2028)
  • Table 246. India Kidney Stone, by End User USD Million (2023-2028)
  • Table 247. South Korea Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 248. South Korea Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 249. South Korea Kidney Stone, by Offering USD Million (2023-2028)
  • Table 250. South Korea Kidney Stone, by Application USD Million (2023-2028)
  • Table 251. South Korea Kidney Stone, by End User USD Million (2023-2028)
  • Table 252. Taiwan Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 253. Taiwan Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 254. Taiwan Kidney Stone, by Offering USD Million (2023-2028)
  • Table 255. Taiwan Kidney Stone, by Application USD Million (2023-2028)
  • Table 256. Taiwan Kidney Stone, by End User USD Million (2023-2028)
  • Table 257. Australia Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 258. Australia Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 259. Australia Kidney Stone, by Offering USD Million (2023-2028)
  • Table 260. Australia Kidney Stone, by Application USD Million (2023-2028)
  • Table 261. Australia Kidney Stone, by End User USD Million (2023-2028)
  • Table 262. Rest of Asia-Pacific Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 263. Rest of Asia-Pacific Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 264. Rest of Asia-Pacific Kidney Stone, by Offering USD Million (2023-2028)
  • Table 265. Rest of Asia-Pacific Kidney Stone, by Application USD Million (2023-2028)
  • Table 266. Rest of Asia-Pacific Kidney Stone, by End User USD Million (2023-2028)
  • Table 267. Europe Kidney Stone, by Country USD Million (2023-2028)
  • Table 268. Europe Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 269. Europe Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 270. Europe Kidney Stone, by Offering USD Million (2023-2028)
  • Table 271. Europe Kidney Stone, by Application USD Million (2023-2028)
  • Table 272. Europe Kidney Stone, by End User USD Million (2023-2028)
  • Table 273. Germany Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 274. Germany Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 275. Germany Kidney Stone, by Offering USD Million (2023-2028)
  • Table 276. Germany Kidney Stone, by Application USD Million (2023-2028)
  • Table 277. Germany Kidney Stone, by End User USD Million (2023-2028)
  • Table 278. France Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 279. France Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 280. France Kidney Stone, by Offering USD Million (2023-2028)
  • Table 281. France Kidney Stone, by Application USD Million (2023-2028)
  • Table 282. France Kidney Stone, by End User USD Million (2023-2028)
  • Table 283. Italy Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 284. Italy Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 285. Italy Kidney Stone, by Offering USD Million (2023-2028)
  • Table 286. Italy Kidney Stone, by Application USD Million (2023-2028)
  • Table 287. Italy Kidney Stone, by End User USD Million (2023-2028)
  • Table 288. United Kingdom Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 289. United Kingdom Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 290. United Kingdom Kidney Stone, by Offering USD Million (2023-2028)
  • Table 291. United Kingdom Kidney Stone, by Application USD Million (2023-2028)
  • Table 292. United Kingdom Kidney Stone, by End User USD Million (2023-2028)
  • Table 293. Netherlands Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 294. Netherlands Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 295. Netherlands Kidney Stone, by Offering USD Million (2023-2028)
  • Table 296. Netherlands Kidney Stone, by Application USD Million (2023-2028)
  • Table 297. Netherlands Kidney Stone, by End User USD Million (2023-2028)
  • Table 298. Rest of Europe Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 299. Rest of Europe Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 300. Rest of Europe Kidney Stone, by Offering USD Million (2023-2028)
  • Table 301. Rest of Europe Kidney Stone, by Application USD Million (2023-2028)
  • Table 302. Rest of Europe Kidney Stone, by End User USD Million (2023-2028)
  • Table 303. MEA Kidney Stone, by Country USD Million (2023-2028)
  • Table 304. MEA Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 305. MEA Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 306. MEA Kidney Stone, by Offering USD Million (2023-2028)
  • Table 307. MEA Kidney Stone, by Application USD Million (2023-2028)
  • Table 308. MEA Kidney Stone, by End User USD Million (2023-2028)
  • Table 309. Middle East Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 310. Middle East Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 311. Middle East Kidney Stone, by Offering USD Million (2023-2028)
  • Table 312. Middle East Kidney Stone, by Application USD Million (2023-2028)
  • Table 313. Middle East Kidney Stone, by End User USD Million (2023-2028)
  • Table 314. Africa Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 315. Africa Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 316. Africa Kidney Stone, by Offering USD Million (2023-2028)
  • Table 317. Africa Kidney Stone, by Application USD Million (2023-2028)
  • Table 318. Africa Kidney Stone, by End User USD Million (2023-2028)
  • Table 319. North America Kidney Stone, by Country USD Million (2023-2028)
  • Table 320. North America Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 321. North America Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 322. North America Kidney Stone, by Offering USD Million (2023-2028)
  • Table 323. North America Kidney Stone, by Application USD Million (2023-2028)
  • Table 324. North America Kidney Stone, by End User USD Million (2023-2028)
  • Table 325. United States Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 326. United States Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 327. United States Kidney Stone, by Offering USD Million (2023-2028)
  • Table 328. United States Kidney Stone, by Application USD Million (2023-2028)
  • Table 329. United States Kidney Stone, by End User USD Million (2023-2028)
  • Table 330. Canada Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 331. Canada Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 332. Canada Kidney Stone, by Offering USD Million (2023-2028)
  • Table 333. Canada Kidney Stone, by Application USD Million (2023-2028)
  • Table 334. Canada Kidney Stone, by End User USD Million (2023-2028)
  • Table 335. Mexico Kidney Stone, by Stone Type USD Million (2023-2028)
  • Table 336. Mexico Kidney Stone, by Treatment Type USD Million (2023-2028)
  • Table 337. Mexico Kidney Stone, by Offering USD Million (2023-2028)
  • Table 338. Mexico Kidney Stone, by Application USD Million (2023-2028)
  • Table 339. Mexico Kidney Stone, by End User USD Million (2023-2028)
  • Table 340. Research Programs/Design for This Report
  • Table 341. Key Data Information from Secondary Sources
  • Table 342. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. United Kingdom Kidney Stone: by Application USD Million (2017-2022)
  • Figure 5. United Kingdom Kidney Stone: by Stone Type USD Million (2017-2022)
  • Figure 6. United Kingdom Kidney Stone: by Treatment Type USD Million (2017-2022)
  • Figure 7. United Kingdom Kidney Stone: by Offering USD Million (2017-2022)
  • Figure 8. United Kingdom Kidney Stone: by Application USD Million (2017-2022)
  • Figure 9. United Kingdom Kidney Stone: by End User USD Million (2017-2022)
  • Figure 10. South America Kidney Stone Share (%), by Country
  • Figure 11. Asia Pacific Kidney Stone Share (%), by Country
  • Figure 12. Europe Kidney Stone Share (%), by Country
  • Figure 13. MEA Kidney Stone Share (%), by Country
  • Figure 14. North America Kidney Stone Share (%), by Country
  • Figure 15. United Kingdom Kidney Stone share by Players 2022 (%)
  • Figure 16. United Kingdom Kidney Stone share by Players (Top 3) 2022(%)
  • Figure 17. United Kingdom Kidney Stone share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 21. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Olympus Corporation (Japan) Revenue: by Geography 2022
  • Figure 23. BD (United States) Revenue, Net Income and Gross profit
  • Figure 24. BD (United States) Revenue: by Geography 2022
  • Figure 25. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Boston Scientific (United States) Revenue: by Geography 2022
  • Figure 27. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 29. Steris plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Steris plc (Ireland) Revenue: by Geography 2022
  • Figure 31. Coloplast A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 32. Coloplast A/S (Denmark) Revenue: by Geography 2022
  • Figure 33. Dornier MedTech (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Dornier MedTech (Germany) Revenue: by Geography 2022
  • Figure 35. Richard Wolf GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Richard Wolf GmbH (Germany) Revenue: by Geography 2022
  • Figure 37. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Siemens Healthineers (Germany) Revenue: by Geography 2022
  • Figure 39. Karl Storz (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Karl Storz (Germany) Revenue: by Geography 2022
  • Figure 41. United Kingdom Kidney Stone: by Application USD Million (2023-2028)
  • Figure 42. United Kingdom Kidney Stone: by Stone Type USD Million (2023-2028)
  • Figure 43. United Kingdom Kidney Stone: by Treatment Type USD Million (2023-2028)
  • Figure 44. United Kingdom Kidney Stone: by Offering USD Million (2023-2028)
  • Figure 45. United Kingdom Kidney Stone: by Application USD Million (2023-2028)
  • Figure 46. United Kingdom Kidney Stone: by End User USD Million (2023-2028)
  • Figure 47. South America Kidney Stone Share (%), by Country
  • Figure 48. Asia Pacific Kidney Stone Share (%), by Country
  • Figure 49. Europe Kidney Stone Share (%), by Country
  • Figure 50. MEA Kidney Stone Share (%), by Country
  • Figure 51. North America Kidney Stone Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Stryker Corporation (United States)
  • Olympus Corporation (Japan)
  • BD (United States)
  • Boston Scientific (United States)
  • Johnson & Johnson (United States)
  • Steris plc (Ireland)
  • Coloplast A/S (Denmark)
  • Dornier MedTech (Germany)
  • Richard Wolf GmbH (Germany)
  • Siemens Healthineers (Germany)
  • Karl Storz (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 215 Pages 60 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
United Kingdom Kidney Stone Market Quantitative research analysis
United Kingdom Kidney Stone Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Stryker Corporation (United States), Olympus Corporation (Japan), BD (United States), Boston Scientific (United States), Johnson & Johnson (United States), Steris plc (Ireland), Coloplast A/S (Denmark), Dornier MedTech (Germany), Richard Wolf GmbH (Germany), Siemens Healthineers (Germany) and Karl Storz (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Adoption of Minimally Invasive Stone Removal Procedure " is seen as one of major influencing trends for Kidney Stone Market during projected period 2022-2028.
The Kidney Stone market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Kidney Stone Market to reach USD4029.0 Million by 2028.

Know More About United Kingdom Kidney Stone Market Report?

Have a Query? Click Here

Other Related Reports

Dental Industry Comprehensive Study by Application (Maintaining Oral Health, Pain Management, Enhancing Aesthetics, Diagnosis and Treatment of Oral Diseases, Others), Offering (Service (Preventive Se...
$ 3800
COVID-19 Sample Collection Kits- Comprehensive Study by Application (Research Organization, Laboratories, Hospitals and Clinics, Resedential), Sample Type (Swabs (Nasopharyngeal, Oropharyngeal, Nasal...
$ 3800
Ear Health Comprehensive Study by Application (Hearing Loss Treatment, Balance Disorders Treatment, Ear Infection Treatment, Tinnitus Management, Others), Product Type (Hearing Aids, Hearing Implants...
$ 3800
Pregnancy and Fertility Testing- Comprehensive Study by Type (Pregnancy Test Kits (Line Pregnancy Tests, Digital Devices), Fertility /Ovulations Test Kits (Ovulation Predictor Kits ,Fertility Monitor...
$ 3800
Diagnostic Testing Comprehensive Study by Type (Invasive (Blood Sample, Biopsy, Colonoscopy, Gastroscopy, Others), Non-Invasive ( X-rays, MRIs, Ultrasounds, Electrocardiogram, Others)), Application (...
$ 3800
Antibody Therapeutics- Comprehensive Study by Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug conjugates, Bispecific Antibody, Radio-immunotherapy, Antibody Fragment, Others), ...
$ 3800